X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34) 34
index medicus (34) 34
cardiovascular (28) 28
female (23) 23
male (23) 23
middle aged (21) 21
pharmacology & pharmacy (18) 18
adult (15) 15
aged (15) 15
cholesterol (13) 13
cholesterol, ldl - blood (13) 13
lipids (13) 13
abridged index medicus (12) 12
safety (12) 12
drug therapy, combination (11) 11
hypercholesterolemia - drug therapy (11) 11
coronary-heart-disease (10) 10
double-blind method (10) 10
hypercholesterolemia (10) 10
cardiac & cardiovascular systems (9) 9
efficacy (9) 9
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (9) 9
atorvastatin calcium (8) 8
internal medicine (8) 8
statins (8) 8
treatment outcome (8) 8
cardiovascular disease (7) 7
drug therapy (7) 7
dyslipidemias - drug therapy (7) 7
hypolipidemic agents - therapeutic use (7) 7
atherosclerosis (6) 6
cardiology and cardiovascular medicine (6) 6
cholesterol - blood (6) 6
density-lipoprotein cholesterol (6) 6
dyslipidemia (6) 6
ezetimibe (6) 6
low density lipoproteins (6) 6
risk factors (6) 6
simvastatin (6) 6
therapy (6) 6
triglycerides (6) 6
adolescent (5) 5
aged, 80 and over (5) 5
care and treatment (5) 5
clinical trials (5) 5
heart-disease (5) 5
heptanoic acids - administration & dosage (5) 5
hypolipidemic agents - adverse effects (5) 5
lipoproteins (5) 5
nicotinic-acid (5) 5
primary hypercholesterolemia (5) 5
pyrroles - administration & dosage (5) 5
risk (5) 5
time factors (5) 5
triglycerides - blood (5) 5
analysis (4) 4
anticholesteremic agents - administration & dosage (4) 4
anticholesteremic agents - adverse effects (4) 4
anticholesteremic agents - therapeutic use (4) 4
atorvastatin (4) 4
cardiology (4) 4
cardiovascular-disease (4) 4
coronary heart-disease (4) 4
delayed-action preparations (4) 4
disease (4) 4
dose-response relationship, drug (4) 4
extended-release niacin (4) 4
follow-up studies (4) 4
hypercholesterolemia - blood (4) 4
hyperlipidemia (4) 4
hyperlipidemias - drug therapy (4) 4
low density lipoprotein (4) 4
low-density lipoprotein cholesterol (4) 4
medicine, general & internal (4) 4
metaanalysis (4) 4
niacin - adverse effects (4) 4
plasma (4) 4
practice guidelines as topic (4) 4
prevention (4) 4
secondary prevention (4) 4
simvastatin - therapeutic use (4) 4
trial (4) 4
atherosclerotic cardiovascular disease (3) 3
cardiovascular agents (3) 3
cholesterol, hdl - blood (3) 3
cholesterol, hdl - drug effects (3) 3
cholesterol, ldl - drug effects (3) 3
clinical recommendations (3) 3
endocrinology, diabetes and metabolism (3) 3
health aspects (3) 3
health policy (3) 3
heptanoic acids - therapeutic use (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (3) 3
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (3) 3
indoles - administration & dosage (3) 3
indoles - adverse effects (3) 3
ldl cholesterol (3) 3
lipoprotein (3) 3
low-density-lipoprotein (3) 3
niacin (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 25, pp. 2344 - 2353
Objectives The primary objective of this study was to evaluate the low-density lipoprotein cholesterol (LDL-C)–lowering efficacy of 5 SAR236553/REGN727... 
Cardiovascular | Internal Medicine | statin | low-density lipoprotein cholesterol | safety | apolipoprotein-B | PCSK9 | SAR236553/REGN727 | hypercholesterolemia | CUTANEOUS VASCULITIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CHOLESTEROL | CARDIOVASCULAR OUTCOMES | LOW-DENSITY-LIPOPROTEIN | PREVENTION | REDUCTION | DISEASE | 14 RANDOMIZED-TRIALS | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Time Factors | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - blood | Double-Blind Method | Proprotein Convertases - metabolism | Treatment Outcome | Anticholesteremic Agents - adverse effects | Drug Synergism | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Aged | Serine Endopeptidases - metabolism | Proprotein Convertase 9 | Care and treatment | Serine | Low density lipoproteins | Antibodies | Thrombin | Lipoprotein A | Cholesterol | Cardiovascular agents | Antilipemic agents | Viral antibodies | Complications and side effects | Hypercholesterolemia | Proteases | Monoclonal antibodies | Universities and colleges | Laboratories | Lipids | Triglycerides | Lipoproteins | Pain | Influenza | Patient safety | Population | Mutation | Clinical medicine | Diabetes | Statins | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2007, Volume 99, Issue 6, pp. S1 - S2
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2015, Volume 9, Issue 2, pp. 129 - 169
Journal Article
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 5, pp. 711 - 715
Journal Article
Journal of Clinical Lipidology, ISSN 1933-2874, 2015, Volume 9, Issue 6, pp. S1 - S122.e1
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2016, Volume 117, Issue 12, pp. 1928 - 1933
Journal Article